OppenheimerFunds’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.01M Buy
396,098
+91,319
+30% +$734K ﹤0.01% 815
2018
Q4
$2.52M Sell
304,779
-70,673
-19% -$676K ﹤0.01% 831
2018
Q3
$3.72M Buy
375,452
+36,485
+11% +$378K ﹤0.01% 817
2018
Q2
$3.31M Buy
338,967
+33,443
+11% +$328K ﹤0.01% 830
2018
Q1
$2.84M Sell
305,524
-19,868
-6% -$189K ﹤0.01% 824
2017
Q4
$3.09M Buy
325,392
+18,851
+6% +$180K ﹤0.01% 849
2017
Q3
$3.17M Sell
306,541
-112,535
-27% -$1.04M ﹤0.01% 854
2017
Q2
$3.47M Sell
419,076
-46,813
-10% -$351K ﹤0.01% 848
2017
Q1
$3.35M Buy
465,889
+103,876
+29% +$753K ﹤0.01% 870
2016
Q4
$2.58M Buy
362,013
+69,019
+24% +$480K ﹤0.01% 887
2016
Q3
$2.13M Buy
292,994
+15,505
+6% +$98.6K ﹤0.01% 879
2016
Q2
$1.63M Buy
277,489
+6,027
+2% +$39.9K ﹤0.01% 897
2016
Q1
$1.73M Buy
271,462
+1,826
+0.7% +$9.8K ﹤0.01% 899
2015
Q4
$1.73M Buy
+269,636
New +$1.69M ﹤0.01% 923

Other funds holding SEM

OppenheimerFunds's SEM Position: Q1 2019 in Review

OppenheimerFunds increased its Select Medical (SEM) stake by 30% in Q1 2019, buying an estimated $734K and bringing the position to 396,098 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #815.

OppenheimerFunds first reported a position in SEM in Q4 2015 and has held it in 14 quarters since. The position peaked at $3.72M in Q3 2018. 203 funds tracked by Wall St. Rank hold SEM as of Q1 2019.

  • OppenheimerFunds held 396,098 shares of Select Medical worth $3.01M as of Q1 2019.
  • OppenheimerFunds bought 91,319 Select Medical shares in Q1 2019, an estimated $734K.
  • Select Medical made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #815 holding.
  • OppenheimerFunds first reported a position in Select Medical in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Select Medical position peaked at $3.72M in Q3 2018.
  • 203 funds tracked by Wall St. Rank held Select Medical as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.